Dimerix shares plunged 35–40% amid heavy selling and uncertainty around clinical updates, worsened by weak biotech sentiment. Further downside depends on results and the funding outlook, though volatility in early-stage biotech stocks suggests a potential for sharp rebounds.
Resolution Minerals (ASX: RML) has rebounded from $0.04 toward $0.07–$0.08, driven by U.S. critical minerals progress and rising investor interest. Despite volatility, strong project developments, infrastructure moves, and drilling activity are shifting sentiment and supporting renewed momentum.
LaserBond (ASX: LBL) is a niche industrial tech company that extends the life of heavy equipment for sectors like mining and energy. It delivers strong margins and cash flow, with growth driven by acquisitions, OEM partnerships, and rising demand for refurbishment solutions. The stock trades on reasonable valuations with a dividend, offering upside if growth and momentum continue.
Lodestar Minerals has surged ~129% YTD after a breakout to ~$0.028, with potential upside toward $0.03–$0.04 if momentum continues. However, as an early-stage explorer, gains are likely event-driven and volatile, with sustainability dependent on exploration success.
1414 Degrees is an ASX-listed cleantech company developing silicon-based thermal storage, hydrogen and battery materials; investor interest reflects Aurora and SiNTL progress, fresh $2.69 million funding, and a high-volume share-price breakout that now needs follow-through.
